Guardant Health is a diagnostics company focused on fundamentally changing the way cancer is managed. The company's proprietary technology enables comprehensive real-time monitoring of cancer through a simple blood test. Current treatment often requires biopsies, which are risky, costly and consequently cannot be used to capture genetic changes that typically lead to treatment failure. The company's technology enables physicians to finally see these genetic changes in real-time and treat them with the appropriate therapies.